BIO.News Newsletter

On World Health Day, we explore links between human health, the climate crisis, and equity—and the role for biotech. Following last week’s trade policy hearings, we see momentum to address biotech issues in Mexico and the EU. (712 words, 3 minutes, 33 seconds)

BIO’s Dr. Cartier Esham and HHS Secretary Xavier Becerra appeared before Senate Committees yesterday. As CMS prepares to announce its final coverage decision for a revolutionary Alzheimer’s drug, a study looks at why the outcome matters for this drug and future drugs requiring real-world evidence. (854 words, 4 minutes, 16 seconds)

Oregon has proposed a plan to restrict coverage of accelerated approval drugs—here’s why that’s a bad idea (and what you can do about it). Today, we’re watching BIO’s Dr. Cartier Esham testify on FDA user fee agreements, and BIO member Gevo testify on renewable energy opportunities in the farm bill. (803 words, 4 minutes)

Catch up on what the U.S. Trade Representative said about a reported TRIPS waiver “compromise” and biotech solutions to reduce gas prices. (793 words, 3 minutes, 57 seconds)

It’s April Fool’s Day—but Mexico’s treatment of biotech is no joke. We have a recap of this week’s hearings on the administration’s trade agenda, which covered Mexico, the EU, and more. Plus, BIO’s Phyllis Arthur spoke at a POLITICO summit on the many legacies of COVID. (757 words, 3 minutes, 47 seconds)

Bipartisan Members of Congress call for prioritizing agriculture in the new Indo-Pacific Economic Framework. A recent report explains why there’s high unmet need in treating serious mental illness and potential policy solutions. Plus, we’re watching a House vote on an insulin cap and HHS Secretary Xavier Becerra’s testimony today. (856 words, 4 minutes, 16 seconds)

BIO’s Federal Government Relations team took a deep dive into President Biden’s proposed budget—here’s what you need to know. Plus, more COVID boosters are coming, and a new op-ed from BIO on the threat of AMR. (887 words, 4 minutes, 26 seconds)

A new policy paper explains why we need more funding for pandemic preparedness. Food shortages are coming – but biotech could help mitigate future ones, if we deploy solutions now. (644 words, 3 minutes, 19 seconds)

Beginning a new week with an explainer on Cures 2.0 and recent exhibits on the National Mall highlighting agriculture and women in STEM. Today, we’ll be watching to see what’s in President Biden’s FY23 budget. (604 words, 3 minutes, 1 second)

What lessons did we learn on supply chains and pandemic preparedness from COVID-19? How would allowing the federal government to exercise “march-in” rights harm university research and future innovation? We answer these questions. (647 words, 3 minutes, 14 seconds)